Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added Cutaneous neuroendocrine carcinoma as a related term and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center. These changes expand contextual references but do not modify the study’s core details, eligibility criteria, outcomes, or locations.
    Difference
    0.2%
    Check dated 2026-04-03T05:30:38.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T21:14:18.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:10:04.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Footer revision indicator updated from v3.4.1 to v3.4.2; no other content or study details appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:39:54.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision indicator updated in the page footer from v3.4.0 to v3.4.1. There are no observed changes to the study's content or site navigation.
    Difference
    0.1%
    Check dated 2026-02-04T23:00:37.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Show glossary toggle has been added to the page. QC-related and version metadata have been updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the prior labels and text such as 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4', with capitalization adjustments for 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T19:15:36.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.